| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Andrew Roy Stanleick last filed a Form 4 in August 2023, as Chief Executive Officer at SKIN. Andrew Roy Stanleick's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 702,933 shares of SKIN. Net of sales, the SKIN filings show accumulation of 16,485 shares.
Andrew Roy Stanleick has 4 Form 4 filings on record from February 2022 to August 2023, all as Chief Executive Officer at Beauty Health (SKIN), 2022–2023.
The 4 reported transactions were 3 stock awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $100K and no sales.
The only open-market purchase was 16,485 shares of SKIN at an average $6.05 on August 17, 2023, about $100K. Twelve months later SKIN was down 76%.
Shares as reported in the last Form 4 for each company; the most recent is from August 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2023 | SKIN Beauty Health Co | Chief Executive Officer | Buy | 16,485 | $6.05 | $99,815.03 | +2.4% | -67.1% | -75.6% |